Director Melissa B Epperly sold 41,861 shares of ROIV at $28.68 for $1.2M, reducing stake by -72.6%.
Melissa B Epperly, as a Director, executed a substantial disposition of 41,861 shares (representing -72.6% of her pre-transaction holdings of 57,665 shares), leaving her with 15,804 shares post-transaction. The sale occurred at $28.68, near the company's 52-week high of $29.72, coinciding with a 30-day price gain of +5.1% and a 90-day gain of +27.6%. The timing raises attention given Roivant's severe operational challenges: the company posted a net loss of $-265,891,000.00 in its most recent full fiscal year, maintains unprofitable operations, and experienced annual revenue contraction of -76.7%. The disparity between a Director's exit from nearly three-quarters of her holdings during a relative strength period and the company's deteriorating financial trajectory warrants investor scrutiny of the transaction's context and forward guidance.